Want to see DERM full AI Analyst Report?
Total Valuation
Journey Medical Corp has a market cap or net worth of $218.74M. The enterprise value is $194.55.
Market Cap$218.74M
Enterprise Value$194.55
Share Statistics
Journey Medical Corp has 22,224,396 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding22,224,396
Owned by Insiders19.48%
Owned by Institutions32.15%
Financial Efficiency
Journey Medical Corp’s return on equity (ROE) is -0.36 and return on invested capital (ROIC) is -14.27%.
Return on Equity (ROE)-0.36
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-14.27%
Return on Capital Employed (ROCE)-0.14
Revenue Per Employee1.07M
Profits Per Employee-197.09K
Employee Count58
Asset Turnover0.65
Inventory Turnover2.62
Valuation Ratios
The current PE Ratio of Journey Medical Corp is ―. Journey Medical Corp’s PEG ratio is 0.47.
PE Ratio―
PS Ratio3.05
PB Ratio5.93
Price to Fair Value5.93
Price to FCF-15.18
Price to Operating Cash Flow-28.44
PEG Ratio0.47
Income Statement
In the last 12 months, Journey Medical Corp had revenue of 61.86M and earned -11.43M in profits. Earnings per share was -0.47.
Revenue61.86M
Gross Profit36.68M
Operating Income-8.17M
Pretax Income-11.37M
Net Income-11.43M
EBITDA-3.33M
Earnings Per Share (EPS)-0.47
Cash Flow
In the last 12 months, operating cash flow was -7.49M and capital expenditures 0.00, giving a free cash flow of -7.49M billion.
Operating Cash Flow-7.49M
Free Cash Flow-7.49M
Free Cash Flow per Share-0.34
Dividends & Yields
Journey Medical Corp pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.47
52-Week Price Change4.73%
50-Day Moving Average6.68
200-Day Moving Average6.99
Relative Strength Index (RSI)70.00
Average Volume (3m)293.66K
Important Dates
Journey Medical Corp upcoming earnings date is Nov 11, 2026, Before Open (Confirmed).
Last Earnings DateAug 12, 2026
Next Earnings DateNov 11, 2026
Ex-Dividend Date―
Financial Position
Journey Medical Corp as a current ratio of 1.79, with Debt / Equity ratio of 79.53%
Current Ratio1.79
Quick Ratio1.53
Debt to Market Cap0.13
Net Debt to EBITDA-0.39
Interest Coverage Ratio-2.21
Taxes
In the past 12 months, Journey Medical Corp has paid 60.00K in taxes.
Income Tax60.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Journey Medical Corp EV to EBITDA ratio is -57.16, with an EV/FCF ratio of -15.29.
EV to Sales3.07
EV to EBITDA-57.16
EV to Free Cash Flow-15.29
EV to Operating Cash Flow-15.29
Balance Sheet
Journey Medical Corp has $25.64M in cash and marketable securities with $25.54M in debt, giving a net cash position of $102.00K billion.
Cash & Marketable Securities$25.64M
Total Debt$25.54M
Net Cash$102.00K
Net Cash Per Share<$0.01
Tangible Book Value Per Share$0.17
Margins
Gross margin is 62.24%, with operating margin of -13.21%, and net profit margin of -18.48%.
Gross Margin62.24%
Operating Margin-13.21%
Pretax Margin-18.38%
Net Profit Margin-18.48%
EBITDA Margin-5.38%
EBIT Margin-12.40%
Analyst Forecast
The average price target for Journey Medical Corp is $13.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$13.50
Price Target Upside111.93% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast20.89%
EPS Growth Forecast40.71%